Vaughn Whittaker
Transplant Surgery · Syracuse, NYNPI 1982866513
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $1,768 of the $2,727 with a category attached, or 64.8%. 9 manufacturers reported payments, led by Transmedics, Inc. at 33.8% of the total. Reporting peaked in 2024 at $1,134 and has fallen 89.5% since, to $119 in 2025.
Across 15 payments — averaging $181.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Transmedics, Inc.$922
- Intuitive Surgical$846
- Veloxis Pharmaceuticals, Inc.$415
- Polynovo North America LLC$273
- Medline Industries LP$124
- E.r. Squibb & Sons, L.L.C.$92
- plus $54 from 3 others
Across 20 payments — averaging $4659.74 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Vanda Pharmaceuticals Inc.$80K
- Otsuka Pharmaceutical Development & Commercialization, Inc.$13K
- Amgen$652
What the payments were for
- Travel & lodging$1,76865%
- Food & beverage$95935%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Transmedics, Inc. | 1 | $922 |
| Intuitive Surgical | 3 | $846 |
| Veloxis Pharmaceuticals, Inc. | 3 | $415 |
| Polynovo North America LLC | 3 | $273 |
| Medline Industries LP | 1 | $124 |
| E.r. Squibb & Sons, L.L.C. | 1 | $92 |
| Angiodynamics, Inc. | 1 | $28 |
| BD | 1 | $14 |
| Lemaitre Vascular, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,727 in reported general payments places this provider in the 60th percentile of 72 transplant surgery providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other transplant surgery in Syracuse
- Rauf ShahbazovSyracuse$3K
- Matthew HanlonSyracuse$1K
- Fauzia ButtSyracuse$988
- Kamran KhanmoradiSyracuse$389
- Matthew GarnerSyracuse$182
- Roberto Hernandez AlejandroRochester$524K
- Tejinder SinghAlbany$513K
- Kishore IyerNew York$95K
- Jason HawksworthNew York$91K
- Parissa TabrizianNew York$74K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.